For carriers of the high-penetrance cancer-susceptibility genes BRCA1 and BRCA2, the life-time risk of ovarian cancer, and particularly high-grade serous carcinoma, is between 40–70 and 20–50%, respectively [16, 17]. This evidence concerns the gene BRCA1 and ovarian carcinoma.